You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CIPROFLOXACIN AND DEXAMETHASONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ciprofloxacin And Dexamethasone patents expire, and what generic alternatives are available?

Ciprofloxacin And Dexamethasone is a drug marketed by Dr Reddys, Sentiss, and Sun Pharm. and is included in three NDAs.

The generic ingredient in CIPROFLOXACIN AND DEXAMETHASONE is ciprofloxacin; dexamethasone. There are thirty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin And Dexamethasone

A generic version of CIPROFLOXACIN AND DEXAMETHASONE was approved as ciprofloxacin; dexamethasone by DR REDDYS on August 10th, 2020.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIPROFLOXACIN AND DEXAMETHASONE?
  • What are the global sales for CIPROFLOXACIN AND DEXAMETHASONE?
  • What is Average Wholesale Price for CIPROFLOXACIN AND DEXAMETHASONE?
Summary for CIPROFLOXACIN AND DEXAMETHASONE
US Patents:0
Applicants:3
NDAs:3
Finished Product Suppliers / Packagers: 5
Raw Ingredient (Bulk) Api Vendors: 3
Clinical Trials: 14
Patent Applications: 60
What excipients (inactive ingredients) are in CIPROFLOXACIN AND DEXAMETHASONE?CIPROFLOXACIN AND DEXAMETHASONE excipients list
DailyMed Link:CIPROFLOXACIN AND DEXAMETHASONE at DailyMed
Drug patent expirations by year for CIPROFLOXACIN AND DEXAMETHASONE
Recent Clinical Trials for CIPROFLOXACIN AND DEXAMETHASONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Campinas, BrazilPhase 2
St. Paul's Hospital, CanadaPhase 4
Santen Pharmaceutical Co., Ltd.Phase 1/Phase 2

See all CIPROFLOXACIN AND DEXAMETHASONE clinical trials

US Patents and Regulatory Information for CIPROFLOXACIN AND DEXAMETHASONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys CIPROFLOXACIN AND DEXAMETHASONE ciprofloxacin; dexamethasone SUSPENSION/DROPS;OTIC 205548-001 Aug 10, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sentiss CIPROFLOXACIN AND DEXAMETHASONE ciprofloxacin; dexamethasone SUSPENSION/DROPS;OTIC 215768-001 Jun 9, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm CIPROFLOXACIN AND DEXAMETHASONE ciprofloxacin; dexamethasone SUSPENSION/DROPS;OTIC 210470-001 Aug 30, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.